(Q48784143)

15 February 2018

title

Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine (English)

1 reference

15 February 2018

1 reference

H J Kang

1 reference

15 February 2018

M G Wientjes

series ordinal

1 reference

15 February 2018

J L Au

series ordinal

1 reference

15 February 2018

publication date

1 March 1997

1 reference

15 February 2018

published in

Pharmaceutical Research

1 reference

15 February 2018

volume

1 reference

15 February 2018

issue

1 reference

15 February 2018

page(s)

337-344

1 reference

15 February 2018

Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.

cites work

1 reference

12 December 2020

The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma

1 reference

12 December 2020

Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats

1 reference

12 December 2020

Phase I study of 2',3'-dideoxyinosine: experience with 19 patients at New York University Medical Center

1 reference

12 December 2020

Analysis of Potential Risk Factors Associated with the Development of Pancreatitis in Phase I Patients with AIDS or AIDS-Related Complex Receiving Didanosine

1 reference

12 December 2020

Physiologic model for the pharmacokinetics of 2'deoxycoformycin in normal and leukemic mice.

1 reference

12 December 2020

Pharmacokinetics of dideoxyinosine in pigtailed macaques (Macaca nemestrina) after intravenous and subcutaneous administration

1 reference

12 December 2020

Physiologic modeling of cyclosporin kinetics in rat and man.

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic interactions between lidocaine and verapamil

1 reference

12 December 2020

HTLV-III infection in brains of children and adults with AIDS encephalopathy

1 reference

12 December 2020

Physiological parameters in laboratory animals and humans

1 reference

12 December 2020

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

12 December 2020

A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis

1 reference

12 December 2020

Diabetes mellitus presenting with ketoacidosis following pentamidine therapy in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Nonlinear disposition of intravenous 2',3'-dideoxyinosine in rats

1 reference

12 December 2020

Adverse effects associated with intravenous pentamidine isethionate as treatment of Pneumocystis carinii pneumonia in AIDS patients

1 reference

12 December 2020

Increase of thiopental concentration in tissues of the rat due to an anesthesia with halothane

1 reference

12 December 2020

Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure

1 reference

12 December 2020

Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models

1 reference

12 December 2020

The effect of verapamil on the pharmacokinetics of adriamycin.

1 reference

12 December 2020

Pharmacokinetics of 2',3'-dideoxyinosine in monkeys

1 reference

12 December 2020

Area method for the estimation of partition coefficients for physiological pharmacokinetic models

1 reference

12 December 2020

Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs

1 reference

12 December 2020

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

1 reference

12 December 2020

Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine

1 reference

12 December 2020

Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs

1 reference

12 December 2020

Permeation and metabolism of anti-HIV and endogenous nucleosides in human immune effector cells

1 reference

12 December 2020

Membrane permeation mechanisms of 2',3'-dideoxynucleosides

1 reference

12 December 2020

Tissue pharmacokinetics of 2',3'-dideoxyinosine in rats

1 reference

12 December 2020

Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies

1 reference

12 December 2020

Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine

1 reference

12 December 2020

Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1012002206007

1 reference

15 February 2018

1 reference

15 February 2018